16040889

Source:http://linkedlifedata.com/resource/pubmed/id/16040889

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0152021, umls-concept:C0199176, umls-concept:C0672596, umls-concept:C0750502
pubmed:issue	8
pubmed:dateCreated	2005-7-25
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16040889-15383442
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372434
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/palivizumab
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1468-2044
pubmed:author	pubmed-author:FeltesT FTF, pubmed-author:SimoesEE
pubmed:issnType	Electronic
pubmed:volume	90
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	875-7; author reply 875-7
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:16040889-Antibodies, Monoclonal, pubmed-meshheading:16040889-Antibodies, Monoclonal, Humanized, pubmed-meshheading:16040889-Antiviral Agents, pubmed-meshheading:16040889-Child, Preschool, pubmed-meshheading:16040889-Data Interpretation, Statistical, pubmed-meshheading:16040889-Heart Defects, Congenital, pubmed-meshheading:16040889-Hospitalization, pubmed-meshheading:16040889-Humans, pubmed-meshheading:16040889-Infant, pubmed-meshheading:16040889-Virus Diseases
pubmed:year	2005
pubmed:articleTitle	Palivizumab prophylaxis in haemodynamically significant congenital heart disease.
pubmed:publicationType	Letter, Comment